Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Adherex to discuss development of sodium thiosulfate with FDA advisory committee

Oct. 10, 2011

BAY-1017858 shows promise in vitro and in vivo

Oct. 10, 2011

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Oct. 10, 2011

Millennium withdraws sNDA for Velcade

Oct. 7, 2011

BioCancell recruits first patients in BC-819 pancreatic cancer study

Oct. 7, 2011

Enrollment complete in Peregrine phase II NSCLC trial

Oct. 7, 2011

Pfizer licenses neratinib to Puma Biotechnology

Oct. 7, 2011

New PLK1 inhibitors developed

Oct. 7, 2011

Bavarian Nordic gains rights to NCI anticancer vaccine candidate

Oct. 7, 2011

Millennium Pharmaceuticals discloses updated results from ongoing phase I trial of MLN-9708

Oct. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...